The place of adjuvant and neoadjuvant chemotherapy in the treatment of gastric cancer;Die Bedeutung der adjuvanten und neoadjuvanten Chemotherapie in der Behandlung des Magenkarzinons

Wiener Klinische Wochenschrift

Volumn 108, Issue 16, 1996, Pages 496-504

  Ausch, Ch ^a   Rosen, H R ^a   Schiessel, R ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

clinical review; gastric cancer; therapy

Indexed keywords

CISPLATIN; CYTARABINE; DOXORUBICIN; FLUOROURACIL; LEVAMISOLE; LOMUSTINE; MITOMYCIN C; PICIBANIL; TEGAFUR; THIOTEPA;

ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; REVIEW; STOMACH CANCER;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; HUMANS; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0029739380     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Agboola OL (1994) Adjuvant treatment in gastric cancer. Cancer Treat Rev 20: 217-240
2. Ajani JA, Ota DM, Jackson DE (1991) Current strategies in the management of locoregional and metastatic gastric carcinoma. Cancer 67: 260-265
3. Ajani JM, Ota DM, Jessup M, Ames FC, McBride C, Boddie A (1991) Resectable gastric carcinoma: an evaluation of preoperative and postoperative chemotherapy. Cancer 68: 1501-1505
4. Ajani JM, Mayer RJ, Ota DM, Steele GD, Evans D, Rob M (1993) Preoperative and postoperative chemotherapy for patients with potentially resectable carcinoma. J Natl Cancer Inst 85: 1839-1843
5. Alcobendas F, Milla A, Estape J, et al (1983) Mitomycin C as an adjuvant in resected gastric cancer. Ann Surg 198: 13-17
6. Allum WH, Hallissey MT, Ward LC, et al (1989) A controlled, prospective randomized trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer. Interim report. British stomach group. Br J Cancer 60: 739-744
7. Allum WH, Hallissey MT, Kelly KA, et al (1989) Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British stomach cancer group trial. Lancet i: 571-574
8. Conroy TH, Wils J, Wagener DJTH, et al (1992) Abstr. International Conference on Biology and Treatment of Gastrointestinal Malignancies, p 72
9. Coombes RC, Schein PS, Chilvers CE, et al (1990) A randomized trial comparing adjuvant fluorouracil, doxorubicin and mitomycin with no treatment in operable gastric cancer. ICCG. J Clin Oncol 8: 1362-1369
10. Douglas HO, Stablein DM, Bruckner HM, et al (1982) Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer: the gastrointestinal tumor study group. Cancer 49: 1116-1122
11. Early Breast Cancer Trialist Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339: 1-15, 71-85
12. Engstrom PF, Lavin PT, Douglass HO, et al (1985) Post-operative adjuvant 5-FU plus MeCCNU therapy for gastric cancer patients. Eastern cooperative oncology group study (EST 3275). Cancer 55: 1868-1873
13. Fink U, Schuhmacher C, Stein HJ, Busch R, Feussner H, Dittler HJ, Helmberger A, Böttcher K, Siewert JR (1995) Preoperative chemotherapy for stage III-IV gastric carcinoma, response and outcome after complete resection. Br J Surg 82: 1248-1252
14. Fisher B, Gunduz N, Saffer EA (1983) Influence of the interval between primary tumor removal and chemotherapy on kinetic and growth of metastases. Cancer Res 43: 1488-1492
15. Fisher B, Gunduz N, Coyle J (1989) Presence of a growth stimulating factor in serum following primary tumor removal in mice. Cancer Res 49: 1996-2001
16. Fisher B, Saffer EA, Deutsch M (1986) Influence of irradiation of a primary tumor on labeling index and estrogen receptor index in a distant tumor focus. Int J Radiat Oncol Biol Phys 12: 879-883
17. Goldie JH, Coldman AJ (1979) A mathematical model for relating drug sensitivity of tumors and their spontaneous mutation rate. Cancer Treat Rep 63: 1727-1733
18. Gunduz N, Fisher B, Saffer EA (1979) Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 39: 3861-3866
19. Hamazoe R, Maeta M, Kaibara N (1994) Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer 73: 2048-2052
20. Hermans J, Bonenkamp JJ, Boon MC, Bunt AMG, Ohyama M, Sasako M, Van de Velde CJH (1993) Adjuvant therapy after curative resection for gastric cancer: metaanalysis of randomised trials. J Clin Oncol 11: 1441-1447
21. Higgins GA, Amadeo JH, Smith DE, et al (1983) Efficacy of prolonged intermittent therapy with combined 5-FU and methyl. CCNU following resection for gastric carcinoma A veterans administration surgical oncology group report. Cancer 52: 1005-1012
22. Jakesz R, Dittrich C, Funovics J, et al (1988) The effect of adjuvant chemotherapy in gastric carcinoma is dependent to tumor histology 5-years results of a prospective randomized trial. Rec Results Cancer Res 110: 44-51
23. Kang YK, Choi DW, Kim CM, Lee JI, Hong WS, Paik WS, Moon NM, Lee JO, Kim YK, Kang TV (1992) The effect of neoadjuvant chemotherapy on the surgical outcome of locally advanced adenocarcinoma: interim report of a randomised controlled trial. Proc ASCO 11: 173
24. Kelsen DA, Atiq OT, Saltz L, Niedzwiecki D, Ginn D, Chapman D, Heelan R, Lightdale CH, Vinciguerra VI, Brennan MU (1992) FAMTX versus etopside, doxorubicin and cisplatin: a random assignment tial in gastric cancer. J Clin Oncol 10: 541-548
25. Krook JE, O'Connell R, Wieand HS, et al (1991) A prospective randomized evaluation of intensive course 5-flourouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer. Cancer 67: 2454-2458
26. Lasser PH, Rougier PH, Mahajoubi M, et al (1991) Neoadjuvant chemotherapy (NCT) in locally advanced gastric cancer (LAGC) (abstract ECCO-6). Eur J Cancer [Suppl] 2: 71
27. Leichman L, Silberman H, Leichman C, et al (1990) Neoadjuvant chemotherapy for gastric adenocarcinoma followed by postoperative intraperitoneal chemotherapy. Proc ASCO 9: 109
28. Leichman L, Berry BT (1991) Cisplatin therapy for adenocarcinoma of the stomach. Sem Oncol 18 [Suppl] 3: 25-33
29. Leichman L, Silverman H, Leichman G, Spears CP, Ray M, Muggia FM, Kiyabu M, Laine L, Stain S, Fuerst K, Groshen S, Donovan A (1992) Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer. Southern California pilot program. J Clin Oncol 12: 1933-1942
30. Leichman L, Silverman H, Leichman CG, Laine I, Kiyabu R, Stain S (1993) Intravenous neoadjuvant chemotherapy for operable gastric cancer patients followed by intraperitoneal therapy after successful resection. In: Salmon SE (ed) Adjuvant therapy of cancer, VII. Lippincott, Philadelphia, pp 261-271
31. Leichman L, Crookes P, Leichman CG, Garcia Y, Grohen S, Silverman H (1994) Preoperative systemic chemotherapy for primary gastric cancer followed by intraperitoneal therapy: a final report on 58 patients. Proc ASCO 13: 227
32. Lerner A, Gonin R, Steel GD, Mayer AJ (1992) Etopside Doxirubicin and cisplatin chemotherapy for advanced gastric adenocarcinoma a phase II trial. J Clin Oncol 10: 536-540
33. Macdonald J, Schein P, Wooley P, et al (1980) 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 93: 533-536
34. Nakajima T (1995) Review of adjuvant chemotherapy for gastric cancer. World J Surg 19: 570-574
35. Overmayer BA (1995) Chemotherapeutic palliative approaches in the treatment of breast cancer. Semin Oncol 22 [Suppl] 3: 2-9
36. Plukker JTH, Mulder NH, Yerschueren RCJ (1989) Combined chemotherapeutic/surgical approach of locally advanced gastric cancer of the cardiac and gastric fundus. Abstracts of EORTC Symposium on Advances in Gastrointestinal Tract Cancer Research and Treatment. leyden, p 41
37. Roder JD, Stein HJ, Böttcher K, Siewert JR (1995) Surgical therapy for gastric cancer. J Infus Chemother 5: 97-103
38. Rosen HR, Scheithauer W, Jakesz R, Böhmig HJ, Schennach W, Depisch D, Hausmaninger H, Stierer M, Sebesta C. Schiessel R (1995) Epirubicin, etopside and cisplatin in the treatment of locally advanced nonresectable gastric carcinoma. Results of a multicentric pilot study. GI Cancer 1: 49-53
39. Rougier PH, Lasser PH, Ducreux M, Mahjoubi M, Bongel C, Elias D (1994) Preoperative chemotherapy of locally advanced gastric cancer. Ann Oncol 5 [Suppl]: 59-68
40. Sautner T, Hofbauer F, Depisch D, et al (1994) Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. J Clin Oncol 12: 970-974
41. Siewert JR, Böttcher K, Roder JD, et al (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 80: 1015-1018
42. Stephens FO (1994) The role of regional chemotherapy in gastric cancer. Europ J Surg Oncol 20: 187-188
43. Sugiyama K, Sato H, Ishizuka K, et al (1992) Preoperative role of angiotensin II induced hypertension chemotherapy in advanced gastric carcinoma. Gan TO Kagaku Ryoho 19: 203-209
44. Takahashi T, Hagiwara A, Shimotsuma M (1994) Intraperitoneal chemotherapy with mitomycin C bound activated carbon particles for patients with advanced gastric cancer. Europ J Surg Oncol 20: 183-184
45. Takahashi T, Hagiwara A, Shimotsuma M, Sawai K, Yamaguchi T (1995) Prophylaxis and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles. World J Surg 19: 565-569
46. Veronesi U, Bonadonna G, Zurrida S, et al (1995) Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann Surg 222: 612-618
47. Wilke HJ, Preusser P, Fink U, Achterrath W, Meyer HJ, Stahl M, Lenaz L, Meyer J, Siewert JR, Geerlings H, Köhne-Wömper CH, Harstrick A, Schmoll HJ (1990) New developments in the treatment of gastric carcinoma. Semin Oncol 17 [Suppl] 2: 61-70
48. Wils J, Klein HO, Wagener DJTH, et al (1991) Sequential high dose methotrexate and 5-fluorouracil combined with doxorubicin: a step ahead in the treatment of advanced gastric cancer. A trial of the EORTC gastro-intestinal (GI) tract cooperative group. J Clin Oncol 9: 827-831
49. Wils JA (1992) Chemotherapy for gastrointestinal cancer: new hopes or new disapointments? Scand J Gastroenterol 27 [Suppl] 194: 87-94
50. Wils J, Meyer HJ, Wilke H (1994) Current status and future directions in the treatment of localized gastric cancer. Ann Oncol 5 [Suppl] 3: 69-72